221 related articles for article (PubMed ID: 21555290)
1. Conjoint analysis of patient preferences on Medicare medication therapy management.
Hong SH; Liu J; Wang J; Brown L; White-Means S
J Am Pharm Assoc (2003); 2011; 51(3):378-87. PubMed ID: 21555290
[TBL] [Abstract][Full Text] [Related]
2. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
[TBL] [Abstract][Full Text] [Related]
3. Perceptions of patients on Medicare Part D medication therapy management services.
Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
[TBL] [Abstract][Full Text] [Related]
4. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
Wang J; Hong SH; Meng S; Brown LM
Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
[TBL] [Abstract][Full Text] [Related]
5. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
[TBL] [Abstract][Full Text] [Related]
6. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
[TBL] [Abstract][Full Text] [Related]
7. Strategies for community-based medication management services in value-based health plans.
Smith MA; Spiggle S; McConnell B
Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
[TBL] [Abstract][Full Text] [Related]
8. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
Millonig MK
J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
[TBL] [Abstract][Full Text] [Related]
9. Patient preferences and willingness-to-pay for community pharmacy-led Medicare Part D consultation services: A discrete choice experiment.
Murry LT; Viyurri B; Chapman CG; Witry MJ; Kennelty KA; Nayakankuppam D; Doucette WR; Urmie J
Res Social Adm Pharm; 2023 May; 19(5):764-772. PubMed ID: 36710174
[TBL] [Abstract][Full Text] [Related]
10. Patient satisfaction with a pharmacist-provided telephone medication therapy management program.
Moczygemba LR; Barner JC; Brown CM; Lawson KA; Gabrillo ER; Godley P; Johnsrud M
Res Social Adm Pharm; 2010 Jun; 6(2):143-54. PubMed ID: 20511113
[TBL] [Abstract][Full Text] [Related]
11. Patients' needs and interests in a self-pay medication therapy management service.
Friedrich M; Zgarrick D; Masood A; Montuoro J
J Am Pharm Assoc (2003); 2010; 50(1):72-7. PubMed ID: 20097642
[TBL] [Abstract][Full Text] [Related]
12. Understanding the landscape of MTM programs for Medicare. Part D: Results from a study for the Centers for Medicare & Medicaid services.
Shoemaker SJ; Hassol A
J Am Pharm Assoc (2003); 2011; 51(4):520-6. PubMed ID: 21752775
[TBL] [Abstract][Full Text] [Related]
13. Contingent valuation and pharmacists' acceptable levels of compensation for medication therapy management services.
Wang J; Hong SH
Res Social Adm Pharm; 2015; 11(3):e121-32. PubMed ID: 22436583
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries.
Welch EK; Delate T; Chester EA; Stubbings T
Ann Pharmacother; 2009 Apr; 43(4):603-10. PubMed ID: 19318600
[TBL] [Abstract][Full Text] [Related]
15. Texas pharmacists' opinions about and plans for provision of medication therapy management services.
Moczygemba LR; Barner JC; Roberson K
J Am Pharm Assoc (2003); 2008; 48(1):38-45. PubMed ID: 18192129
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services.
Branham AR; Katz AJ; Moose JS; Ferreri SP; Farley JF; Marciniak MW
J Pharm Pract; 2013 Aug; 26(4):420-7. PubMed ID: 23178415
[TBL] [Abstract][Full Text] [Related]
17. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes.
Fox D; Ried LD; Klein GE; Myers W; Foli K
J Am Pharm Assoc (2003); 2009; 49(2):192-9. PubMed ID: 19289345
[TBL] [Abstract][Full Text] [Related]
18. Impact of a Medicare MTM program: evaluating clinical and economic outcomes.
Hui RL; Yamada BD; Spence MM; Jeong EW; Chan J
Am J Manag Care; 2014 Feb; 20(2):e43-51. PubMed ID: 24738554
[TBL] [Abstract][Full Text] [Related]
19. Perceived value of a home-based medication therapy management program for the elderly.
Moultry AM; Poon IO
Consult Pharm; 2008 Nov; 23(11):877-85. PubMed ID: 19072012
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting demand among older adults for medication therapy management services.
Brooks JM; Unni EJ; Klepser DG; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2008 Dec; 4(4):309-19. PubMed ID: 19064238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
